From Silos
To Synergy
From Silos to Synergy
A Top 10 pharmaceutical company needed to align multiple global brand teams under a unified therapeutic area strategy—something never attempted in their organization. The barrier wasn't capability but entrenched thinking patterns that positioned teams as competitors rather than collaborators. They needed help cutting through these mental barriers to see solutions hidden in plain sight.
The Challenge Ahead
As we worked with them to develop their therapeutic area strategy, three critical challenges emerged:
- Brand teams operated independently—challenging this fundamental assumption, not just combining plans, was the real issue.
- Competing priorities across imminent launches and product lifecycle transitions created tension between immediate market demands and future growth planning, forcing difficult resource trade-offs.
- Strategy required alignment across global functions, regional markets, and stakeholders in three high-profile disease areas.
How We Helped
We transformed complex problems into actionable solutions by:
- Mapping the conversational terrain before diving in, helping leaders identify the true north of their collaboration before navigating sensitive cross-functional discussions.
- Supporting decision making about how a portfolio strategy would actually make them more competitive, and what the implications looked like at the brand and indication level.
- Distilling complex strategic choices into a clear narrative that answered fundamental questions for a very senior audience.
Our Impact
The strategy delivered immediate and lasting results:
- Secured nine-figure incremental investment in the TA.
- Elevated the profile of the TA with a cohort of local GMs to navigate a transition.
- Created aligned execution plans across 20+ markets and multiple products.
"The clarity of the strategy and quality of engagement to get there were outstanding. This output is now the standard leadership wants across the enterprise."
— Global TA Head